Proprio is a surgical technology company based in Seattle that has developed an innovative system called Paradigm to revolutionize the way surgeons perform complex procedures. Paradigm utilizes cutting-edge technologies such as light field imaging, computer vision, machine learning, robotics, and augmented reality to provide surgeons with real-time, three-dimensional visualizations of the surgical field.
The system captures high-definition images of the operating area and fuses them with preoperative 3D scans of the patient's anatomy. This allows surgeons to visualize key structures, including those that are difficult or impossible to see with the naked eye, in an immersive 3D environment. The generated images adapt to shifts in the anatomy, updating in real-time, eliminating the need for repeated intraoperative scans and reducing radiation exposure.
Paradigm has been primarily tested for spinal and cranial surgeries, which are among the most complex and revenue-generating procedures for hospitals. The system aims to increase surgical accuracy, reduce complications and revisions, decrease operating room time, and improve overall patient outcomes. In April 2023, Proprio received 510(k) clearance from the US Food and Drug Administration (FDA) for Paradigm, paving the way for its commercial launch.
The company's technology also holds potential for surgical training and data collection. Paradigm can capture a wealth of data during procedures, enabling analysis and potential predictive capabilities to further enhance surgical techniques and outcomes.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.